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Asthma is a serious global health problem. People of all ages in 
countries throughout the world are affected by this chronic airway 
disorder that when uncontrolled can place severe limits on daily 
life and can be fatal. The prevalence of asthma is increasing in most 
countries, especially amongst children. It is now estimated that as 
many as 300 million people of all ages and all ethnic backgrounds 
suffer from asthma. The burden of this disease on the government, 
health care systems, families, and patients is increasing worldwide. 
The increase in the prevalence of asthma has been associated with 
an increase in atopic sensitization, and is paralleled by similar 
increases in other allergic disorders such as eczema and rhinitis. 
Effective management of asthma in children requires the de-
velopment of a partnership between the parents/caregivers of the 
patient with asthma, and his or her health care professionals. Simple 
educational interventions (designated to teach self-management 
skills) amongst children admitted to the hospital have shown to 
significantly reduce readmission and morbidity rates. The goals 
for successful management of asthma are to achieve and maintain 
control of the symptoms, maintain normal activity levels (inclu-
ding exercise), maintain pulmonary function as close to normal 
as possible, prevent asthma exacerbation, avoid adverse effects 
from asthma medications, and prevent asthma mortality. These 
goals for therapy reflect an understanding of asthma as a chronic 
inflammatory disorder of the airways characterized by recurrent 
episodes of wheezing, breathlessness, chest tightness and coughing. 
Clinical studies have shown that asthma can be effectively control-
led by intervention to suppress and reverse inflammation, as well 
as treating the bronchoconstriction related symptoms. 
Although pharmacologic intervention to treat established 
asthma is highly effective in controlling symptoms and improving 
quality of life, measures to prevent the development of asthma by 
avoiding or reducing exposure to risk factors should be imple-
mented wherever possible. Asthma exacerbations may be caused 
by a variety of factors sometimes referred to as triggers, including 
allergens, viral infections, pollutants and drugs. Because many 
asthma patients react to multiple factors that are ubiquitous in 
the environment, avoiding these factors completely is usually im-
practical and very limited to the patient. Therefore, medications 
to maintain asthma control play an important role in maintaining 
health. Each patient is assigned to one of five “treatment steps” 
depending on their current level of control, and treatment is 
adjusted in a continuous cycle driven by changes in their asthma 
control status. This presentation reflects the peculiarities of treat-
ment steps for achieving control in children with asthma. Is also 
describes the prescriptions in long-term treatment with inhalation 
of low, medium, and high doses of glucocorticosteroids, leuco-
triene modifiers, therapies with sustained-release theophylline, 
cromones, long-acting β2 agonists, and anti-IgE treatment in 
patients of different ages. The presentation includes the peculiarity 
of long-term supervision, as well as assessment and monitoring 
of patients with asthma.
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An evaluation was conducted of herpetic infections and clinical 
and immunological features in wheezy children. The study group 
included 54 children with recurrent wheezing, who were admitted 
to the Public Medical and Sanitary Institution Children’s Muni-
cipal Clinical Hospital No. 1 in 2008-2009. Patients were divided 
into 3 groups according to the age: group 1 – children aged 0-12 
months (18.8%), group 2 – 12-24 months of age (62.9%), and 
group 3 – 24-36 months (18.3%). The herpetic infection diagnosis 
was confirmed by the following examination methods: PCR (po-
lymerase chain reaction) and the immunoenzymatic technique. 
Humoral immunity was assessed using the Mancini method and 
cell-mediated immunity was assessed using sheep erythrocytes. All 
patients included in the study had positive family epidemiological 
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anamnesis of herpetic infections. Analysis of the results was carried 
out by means of the medical statistical method.
Children with herpetic infections are at a major risk of recur-
rent wheezing. All examined children had mixed forms of herpetic 
infections (Herpes simplex virus+Cytomegalovirus). Association of 
the acute renal failure with Herpes simplex virus+Cytomegalovirus 
infections has facilitated the apparition of secondary humoral 
and cell-mediated immunological disorders (decrease of CD3, 
CD-4, CD8, and CD-20 levels and also immunoglobulin A and 
G fractions).
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